AstraZeneca News

Case Dismissed: Appeals Court Slams Expert Witness in Diabetes Drug Lawsuits

Multi-district litigation over the diabetes drug saxagliptin, a case that combined more than 80 suits from around the country, has failed because the plaintiffs’ sole expert witness was unreliable and did not show a causal link between the medication and …

AstraZeneca to Pay $425 Million to End US Lawsuits Over Heartburn Drugs

Britain’s AstraZeneca has agreed to pay $425 million to settle about 11,000 lawsuits in the United States that claimed its heartburn drugs Nexium and Prilosec caused chronic kidney disease. AstraZeneca did not admit wrongdoing under the settlement, part of broader …

AstraZeneca Faces 2 London Lawsuits Over COVID-19 Vaccines

AstraZeneca is facing two London lawsuits, including one from the husband of a woman who died after receiving the Anglo-Swedish drugmaker’s COVID-19 vaccine, in the first of potentially dozens of cases brought in England. Britain was the first country to …

Officials of AstraZeneca China Summoned About Probe of Suspected Insurance Fraud

Chinese authorities summoned officials of AstraZeneca China regarding an investigation of suspected medical insurance fraud by the company’s employees, the National Healthcare Security Administration (NHSA) said on Saturday. The regulator of the state medical insurance fund said authorities ordered the …

U.S. Recommends Pausing Use of J&J COVID Vaccine over Rare Blood Clots

U.S. federal health agencies on Tuesday recommended pausing use of Johnson & Johnson’s COVID-19 vaccine for at least a few days after six women under age 50 developed rare blood clots after receiving the shot, dealing a fresh setback to …

AstraZeneca to Publish Full COVID-19 Vaccine Clinical Trial Results on Efficacy

AstraZeneca will publish up-to-date results from its major U.S. COVID-19 vaccine trial within 48 hours after health officials publicly criticized the drugmaker for using “outdated information” to show how well the immunization worked. The rare public rebuke marks the latest …

U.S. Oversight Board Questions AstraZeneca’s COVID-19 Vaccine Data

AstraZeneca may have released outdated information on its latest COVID-19 vaccine trial, giving an “incomplete” picture of its efficacy, a leading U.S. health agency said on Tuesday, casting doubt on the shot’s potential U.S. rollout and plunging its developers, once …

EU Threatens to Ban COVID Vaccine Exports to Britain

BRUSSELS – The European Union threatened on Wednesday to ban exports of COVID-19 vaccines to Britain to safeguard scarce doses for its own citizens facing a third wave of the pandemic that would jeopardize plans to restart travel this summer. …

Investor Sues Drugmaker Astrazeneca Over Coronavirus Vaccine Testing Claims

AstraZeneca PLC was sued by a pension fund on behalf of investors who it says suffered losses because of flaws in the company’s testing of its coronavirus vaccine. For much of last year, the Cambridge, England-based pharmaceutical company was touting …

Who’s On the Hook If COVID-19 Vaccines Go Wrong?: Viewpoint

The COVID-19 vaccines are here and distribution has begun. But what if something goes wrong? Whether it’s a loss of income, hefty medical bills or other serious adverse effects from getting a shot, someone has to pick up the tab, …